2019 performance
Reports on healthcare service assessment – prepared in 2019
Qualification of healthcare services into the health benefit package:
- prosthetic restoration supported by implants with postoperative control and possible need to remove implants in patients:
– after oncological treatment in the craniofacial area ICD-10: C:C00, C01, C02, C03, C04, C06, C08, C09, C10, C11, ICD9: 27.3, 27.32, 76.01, 76.01, 76.011, 76.2, 76.3, 76.31, 76.311, 76.312, 76.391, 76.4,
– with congenital craniofacial defects ICD-10: K07.0, K07.1, K07.5, Q37.0, Q37.1, Q37.8, Q37.9, Q38.6, Q67.0, Q67.4, Q75.0-Q75.9, Q87.0, ICD 9: 27.541, 27.542, 76.6, 76.69, 76.9 in the dental medicine;
- upper complete overdenture based on protected roots. Lower complete overdenture based on protected roots in dental medicine;
- relaxing bite splint in dental medicine;
- panoramic radiograph with a description performed on the basis of a referral together with a justification for performance of the imaging, in connection with another dental service, 1 radiograph once every 2 years (for root canal treatment in adults) in the dental medicine;
- X-ray diagnostics – a panoramic radiograph with a description once every 5 years in dental medicine;
- testing by microarray-based comparative genomic hybridisation (aCGH) in outpatient specialist care (AOS);
- daily long-term medical care as part of nursing care and services in long-term care.
Removal of healthcare services from the health benefit package:
- removal of procedures from hospital treatment (orthopaedics and traumatology of movement) (according to ICD-9):
– 84.502 – introduction of autologous growth factors,
– 84.503 – introduction of stem cell growth factors.
Change of health technologies:
- in the following oncological indications: C18, C19, C20, C21 colorectal neoplasms in the primary health care, outpatient specialist care, hospital treatment;
- in the following oncological indications: C61 – prostate cancer in the primary health care, outpatient specialist care, hospital treatment;
- in the scope of neurological rehabilitation;
- in the scope of cardiovascular rehabilitation;
- in the scope of systemic rehabilitation;
- in the scope of pulmonary rehabilitation;
- in the scope of paediatric rehabilitation.
Changes in organisation of service provision:
- development (in consultation with stakeholders) of comprehensive oncological care in colorectal neoplasms;
- development (in consultation with stakeholders) of comprehensive oncological care in prostatic neoplasms;
- development (in consultation with stakeholders) of comprehensive oncological care in haematological neoplasms in adults.
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out.
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2024]